Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin II Receptor Blockers: A Comparison of Outcomes in Patients With COVID-19

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Circulation Cardiovascular quality and outcomes 2020-10, Vol.13 (10), p.e007115-e007115
Hauptverfasser:	Kalra, Ankur, Hawkins, Edward S., Nowacki, Amy S., Jain, Vardhmaan, Milinovich, Alex, Saef, Joshua, Thomas, George, Gebreselassie, Surafel K., Karnik, Sadashiva S., Jehi, Lara, Young, James B., Svensson, Lars G., Chung, Mina K., Mehta, Neil
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Angiotensin Receptor Antagonists - therapeutic use Angiotensin-Converting Enzyme Inhibitors - therapeutic use Betacoronavirus Coronavirus Infections - complications Coronavirus Infections - therapy Coronavirus Infections - virology COVID-19 Female Hospitalization - statistics & numerical data Humans Hypertension - complications Hypertension - drug therapy Male Middle Aged Pandemics Pneumonia, Viral - complications Pneumonia, Viral - therapy Pneumonia, Viral - virology Respiration, Artificial - statistics & numerical data Retrospective Studies SARS-CoV-2
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!